Enhanced MRI-guided radiotherapy with gadolinium-based nanoparticles: preclinical evaluation with an MRI-linac
Abstract Background The AGuIX® (NH TherAguix) nanoparticle has been developed to enhance radiotherapy treatment and provide strong MR contrast. These two properties have previously been investigated separately and progressed to clinical trial following a clinical workflow of separate MR imaging foll...
Main Authors: | H. L. Byrne, G. Le Duc, F. Lux, O. Tillement, N. M. Holmes, A. James, U. Jelen, B. Dong, G. Liney, T. L. Roberts, Z. Kuncic |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Cancer Nanotechnology |
Online Access: | http://link.springer.com/article/10.1186/s12645-020-00065-5 |
Similar Items
-
Dosimetric Optimization and Commissioning of a High Field Inline MRI-Linac
by: Urszula Jelen, et al.
Published: (2020-02-01) -
Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
by: Pengcheng Hu, et al.
Published: (2019-11-01) -
New gadolinium contrast agents for MRI
by: Elemento, Elisa
Published: (2008) -
Incidental MRI Findings of Acute Gadolinium Hypersensitivity
by: C. Amene, et al.
Published: (2012-04-01) -
MRI spot sign: Gadolinium contrast extravasation in an expanding intracerebral hematoma on MRI
by: Talha Allam, MD, et al.
Published: (2019-05-01)